Digital PCR Quantification of a Circulating RBP3 and CRX RNA Signature Establishes a Liquid Biopsy Framework for Precision Monitoring of Retinoblastoma
International Journal of Molecular Sciences · 08.05.2026 · 27 (10) · 4177
DOI: 10.3390/ijms27104177 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.05.2026. Verfasst von Thais Biude Mendes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Laboratory, Pediatric Oncology Institute (IOP/GRAACC), Federal University of Sao Paulo, Sao Paulo 04039-001, SP, Brazil. Hauptthemen laut MEDLINE: Retinoblastoma, Homeodomain Proteins, Polymerase Chain Reaction, Cell-Free Nucleic Acids. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRONON (Programa Nacional de Apoio à Atenção Oncológica, National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology - INCT BioOncoPed, PRONON.
Abstract (Originalsprache)
Retinoblastoma (RB) is the most common intraocular malignancy of childhood, yet molecular assessment of disease dissemination and minimal residual disease (MRD) remains challenging due to the contraindication of intraocular biopsy. Here, we evaluate the feasibility of cell-free RNA (cfRNA)- and circulating tumor cell RNA (ctcRNA)-based liquid biopsy for the sensitive detection of disseminated retinoblastoma using digital PCR (dPCR) targeting the retina-specific markers CRX and RBP3. We analyzed 433 bone marrow (BM), peripheral blood (PB) and cerebrospinal fluid (CSF) samples collected longitudinally from 50 patients with RB. dPCR assays demonstrated high analytical sensitivity. cfRNA detection showed complete sensitivity and negative predictive value in bone marrow compared with myelogram analysis, frequently identifying molecular positivity in cytologically negative samples. In cerebrospinal fluid, cfRNA detection was highly specific but less sensitive, reflecting compartment-specific biological constraints. Longitudinal analysis revealed that changes in CRX and RBP3 ctcRNA levels closely tracked treatment response, preceded cytological evidence of bone marrow involvement in several cases, and identified molecular persistence or re-emergence during follow-up, including after hematopoietic stem cell transplantation. Together, these findings demonstrate that cfRNA- and ctcRNA-based liquid biopsy using CRX and RBP3 enables sensitive and dynamic detection of disseminated retinoblastoma, particularly in bone marrow, and supports its potential utility for MRD monitoring. Longitudinal patient analyses will be required to define prognostic thresholds and establish the clinical role of this approach in risk stratification and long-term surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics Laboratory, Pediatric Oncology Institute (IOP/GRAACC), Federal University of Sao Paulo, Sao Paulo 04039-001, SP, Brazil.
- National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90010-150, RS, Brazil.
- Department of Gynecology, Federal University of Sao Paulo, Sao Paulo 04024-002, SP, Brazil.
- Institute of Pediatric Oncology (IOP/GRAACC), Sao Paulo 04023-062, SP, Brazil.
- Ophthalmology Department, Universidade Federal de São Paulo, Sao Paulo 04023-062, SP, Brazil.
ORCID-Profile: Thais Biude Mendes, Francine Tesser Gamba
Förderung
- PRONON (Programa Nacional de Apoio à Atenção Oncológica
- National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology - INCT BioOncoPed
- PRONON
- National Science and Technology Institute for Children’s Cancer Biology and Pediatric Oncology
Zitieren
APA
Mendes, T. B., Oliveira, I. D., Tesser Gamba, F., Lima, F. T., Morales, B. F. S. C., Macedo, C. R. P. D., Teixeira, L. F., & Toledo, S. R. C. (2026). Digital PCR Quantification of a Circulating RBP3 and CRX RNA Signature Establishes a Liquid Biopsy Framework for Precision Monitoring of Retinoblastoma. International Journal of Molecular Sciences, 27(10), 4177. https://doi.org/10.3390/ijms27104177
Vancouver
Mendes TB, Oliveira ID, Tesser Gamba F, Lima FT, Morales BFSC, Macedo CRPD, et al. Digital PCR Quantification of a Circulating RBP3 and CRX RNA Signature Establishes a Liquid Biopsy Framework for Precision Monitoring of Retinoblastoma. International Journal of Molecular Sciences. 2026;27(10):4177. doi:10.3390/ijms27104177
BibTeX
@article{Mendes2026,
author = {Mendes, Thais Biude and Oliveira, Indhira Dias and Tesser Gamba, Francine and Lima, Fernanda Teresa and Morales, Bruna Fernanda Silva Cardoso and Macedo, Carla Renata Pacheco Donato and Teixeira, Luiz Fernando and Toledo, Silvia Regina Caminada de},
title = {Digital PCR Quantification of a Circulating RBP3 and CRX RNA Signature Establishes a Liquid Biopsy Framework for Precision Monitoring of Retinoblastoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4177},
doi = {10.3390/ijms27104177}
}
EUVIMED